Quick Answer
PURE BIOSCIENCE, INC. reported Gross Profit of $1.30 million for the year ending 2025.
- PURE BIOSCIENCE, INC. showed an increase of +13.1% in Gross Profit from 2024 to 2025.
- This data is from PURE BIOSCIENCE, INC.'s annual report (Form 10-K), filed with the SEC on October 29, 2025.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2019: $242.0 thousand | Q1 2020: $207.0 thousand | Q2 2020: $1.25 million | Q4 2020: $950.0 thousand | Q1 2021: $553.0 thousand | Q2 2021: $315.0 thousand | Q4 2021: $329.0 thousand | Q1 2022: $234.0 thousand | Q2 2022: $325.0 thousand | Q4 2022: $257.0 thousand | Q1 2023: $197.0 thousand | Q2 2023: $196.0 thousand | Q4 2023: $442.0 thousand | Q1 2024: $177.0 thousand | Q2 2024: $258.0 thousand | Q4 2024: $325.0 thousand | Q1 2025: $227.0 thousand | Q2 2025: $283.0 thousand | Q4 2025: $450.0 thousand | Q1 2026: $238.0 thousand.
- Over the full 7 years of available data (2019 to 2025), PURE BIOSCIENCE, INC.'s Gross Profit has grown by 10.3%.
- Historical annual values: Fiscal year 2025: $1.30 million | Fiscal year 2024: $1.15 million | Fiscal year 2023: $971.0 thousand | Fiscal year 2022: $1.00 million | Fiscal year 2021: $2.08 million | Fiscal year 2020: $4.02 million | Fiscal year 2019: $1.18 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: